Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...
Pfizer has lagged the broader market over the past year, and analysts remain cautious about its future outlook.
Pharmaceutical operations remain central to large-cap healthcare discussions Balance sheet positioning frames institutional comparisons Broader sentiment reflects themes seen in s&p 500 chart Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results